Georgia Bio Names Milton High School Senior as 2021 Georgia BioGENEius Winner

Priya Soneji Advances to International Competition Against Top Students

ATLANTA–( BUSINESS WIRE )–Georgia Bio and the Georgia BioEd Institute today named  Priya Soneji , a senior at Milton High School in Milton, GA, as the winner of the 2021 Georgia BioGENEius Challenge, the premier competition for high school students that recognizes outstanding research and innovation in the biotechnology field. As Georgia’s BioGENEius finalist, Priya will attend the 2021 International BioGENEius competition, which will be held virtually and featured during the BIO Digital Convention.

“In the biotech industry, young people are the closest thing we have to a crystal ball. The BioGENEius Challenge showcases scientific innovations that are only possible when young minds are given the freedom and resources to convert their ideas into action” Tweet this

Priya will compete against high school students from the U.S., Canada and Germany in the International BioGENEius Challenge. The student projects will represent a range of biotechnology topics such as healthcare, agriculture, and the environment.

Priya was selected as our winner because of the tracking microscope she developed that automatically focuses on a microorganism as it travels through three-dimensional space. Scientists typically observe microorganisms under a microscope by moving the slide or petri dish manually. Priya improved on this method by creating a mechanized device that uses AI to record video and plot the location of an organism as it travels. By enabling scientists to observe microscopic organisms for longer periods of time and more easily identify fast-moving specimens, this device has the potential to facilitate parasite diagnosis and advance the discovery of previously unknown microorganism behaviors.

“In the biotech industry, young people are the closest thing we have to a crystal ball. The BioGENEius Challenge showcases scientific innovations that are only possible when young minds are given the freedom and resources to convert their ideas into action,” said Georgia Bio President and CEO Maria Thacker. “Georgia Bio is thrilled to have Priya represent our state on the international stage at the upcoming BIO Digital Convention, and we are proud to support this Georgia scholar in her future endeavors.”

Georgia Bio also congratulates the Georgia BioGENEius runner-up,  Asmi Kumar,  who is also a student at Milton High School in Milton, GA. Asmi’s project focused on treating Cortical Visual Impairment (CVI) with a low-cost, computer app-based therapy, called FollowMe. CVI occurs when neurological damage in a child’s brain causes a disconnect between the optic nerve and the visual cortex. Typically, the connection is restored through coordination therapies, where parents or therapists move an object around in front of a child so that the child may track it. This method is often expensive, time-consuming, and results in inconsistent feedback on what the child’s eyes are seeing. FollowMe uses AI and a standard webcam to track the patient’s gaze as they follow targets generated in the web-based app, which eliminates the need for expensive therapy visits. Asmi plans to continue the development of FollowMe and hopes to introduce this therapy to doctors around the world.

Judging the 2021 Georgia BioGENEius Challenge were Jamie L. Graham, Boehringer Ingelheim; Ralph L. Cordell, CDC; Ian Biggs, UGA; and Alex Harvey, ViaMune, Inc.

National and International winners will be announced after the competition. See the  International BioGENEius website  for more information on the revised 2021 schedule. Winners will receive cash scholarships.

Follow the BioGENEius Challenge:  Throughout the challenge, @BiotechInstitut will be tweeting interviews, photos, and engaging with the biotechnology community by using the hashtag #BioGENEius.

About the Biotechnology Institute

The Biotechnology Institute is an independent, national nonprofit organization dedicated to education about the present and future impact of biotechnology. Its mission is to engage, excite and educate the public, particularly students and teachers, about biotechnology and its immense potential for solving human health, food and environmental problems. For more information, visit  www.biotechinstitute.org.

About the Georgia BioEd Institute

The Georgia BioEd Institute, a division of the 501(c)(3) nonprofit the Center for Global Health Innovation, works to strengthen Georgia’s life sciences workforce pipeline through classroom-to-career initiatives that align with industry needs. BioEd works closely with its sister organization Georgia Bio, which serves the state’s life science industry. For more information about BioEd, visit them online at  www.georgiabioed.org , or on Facebook (@GeorgiaBioEd), Twitter (@georgiabioed), or LinkedIn (@georgia-bioed).

March 17, 2026
Georgia Life Sciences leads effort to establish bipartisan caucus focused on advancing the state’s growing life sciences economy
March 13, 2026
A skilled workforce is the engine that will drive growth across America’s biotechnology industry, and Atlanta has built multi-faceted training programs that are developing and sustaining the talent pipeline for everything from advanced laboratory research to industrial biomanufacturing.
March 12, 2026
On March 12, 2026, Augusta, Georgia served as the setting for an important conversation about the future of American biotechnology and manufacturing. Manus welcomed members of the U.S. National Security Commission on Emerging Biotechnology (NSCEB) to its Augusta BioFacility to highlight how advanced biomanufacturing is strengthening U.S. supply chain resilience and supporting the growing bioeconomy. During the visit, Manus unveiled a significant expansion of its 44-acre Augusta BioFacility, increasing domestic capacity to produce critical biobased ingredients. The expansion further positions Georgia as a key hub for advanced biomanufacturing and demonstrates the growing role of biotechnology in strengthening national economic and supply chain security. Commission members met with leaders from industry, government, and academia to discuss strategies for scaling manufacturing infrastructure, strengthening resilient supply chains, and preparing the workforce needed to support the next generation of the U.S. bioeconomy. The visit also included conversations with Manus employees about the practical realities of building and operating advanced biomanufacturing facilities in the United States. The Augusta site has become one of the largest advanced biomanufacturing facilities in the country, producing a growing portfolio of bioalternatives at industrial scale. Among these products is high-purity Reb M, recently launched as Yume™ M Stevia Sweetener , supported by an all-Americas supply chain. “As we scale the Manus bioalternatives platform, Augusta has become a powerful example of what the modern U.S. bioeconomy looks like in practice,” said Manus Founder and CEO Ajikumar Parayil. The visit underscores Georgia’s expanding leadership in life sciences manufacturing and highlights how regional ecosystems can help advance U.S. leadership in biotechnology and biomanufacturing. Learn more about the expansion and visit: Manus welcomes U.S. National Security Commission on Emerging Biotechnology to unveil major Augusta BioFacility expansion Growing Georgia Biomanufacturing Industry Transforming American Industrial Strength
MORE POSTS